News

IO Biotech said on Monday its experimental combination vaccine for a type of skin cancer helped slow the disease's ...
Some oncologists and researchers have raised concerns about delays in the completion of confirmatory trials, but FDA now has new tools to push them ahead.
Merck MRK announced mixed second-quarter results last month. The company beat estimates for earnings while meeting the same ...
IO Biotech’s cancer vaccine has “narrowly” failed to beat Merck's blockbuster oncology drug Keytruda in a phase 3 melanoma ...
The system for compensating people injured by vaccines needs significant reform. But the health secretary could alter it in ...
IO Biotech said on Monday its experimental cancer vaccine, in combination with Merck's Keytruda, showed improvement in a late ...